ClinicalTrials.gg
CompletedNCT06428071Updated Oct 26, 2026

Decompression Versus Heat and Decompression in Knee OA

An interventional study of standard physical therapy and knee Decompression in Knee Osteoarthritis, sponsored by University of Hail. Completed at 1 site in Saudi Arabia. Open to participants aged 45 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-10-26.

Sponsored by University of Hail · Not applicable, Interventional, and Treatment

How we know

Updated Oct 26, 2026Start date movedPrimary completion moved+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Randomized
Ages
45 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 27 studies in Osteoarthritis, Knee with a site in Saudi Arabia — 5 open to participants now, 5 under way, none of them phase 3. Osteoarthritis, Knee · Saudi Arabia.

Enrollment
3rd of 24
75 · median 44
Started
2026
with 2 others
No phase
23 of 27
5 open now
Registered
22nd of 27
by date

Among the 27 studies in Osteoarthritis, Knee with a site in Saudi Arabia, this one is the 3rd largest by enrollment of the 24 interventional ones that give a count, is one of 3 that started in 2026, is one of 23 with no phase, and was the 22nd registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

5 of the 27 studies in Osteoarthritis, Knee with a site in Saudi Arabia are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in Saudi Arabia have not opened yet or have stopped. Only those recruiting at a site in Saudi Arabia →

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 45 Years to 60 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 27 studies in Osteoarthritis, Knee with a site in Saudi Arabia, or all of them as a file.
02

Study summary

a randomized controlled trial tends to compare the effects of adding superficial heating during the application of knee decompression session to the results of decompression alone without heating.

Read the detailed description

Osteoarthritis (OA) is a progressive multifactorial joint disease characterized by chronic pain and functional disability due to the degeneration of the articular cartilage. The knee joint is the most vulnerable joint in the human body and occupies four-fifths of the burden of OA worldwide. Subjects having KOA demonstrate deferent clinical and radiological characteristics such as narrowed joint space, osteophytes around the articular surface, subchondral sclerosis, pain, limited range of motion (ROM), and declined functional status.

Except for the arthroplasty for the severely arthritic knee joint, there is no cure for the degeneration of joint cartilage. Medications, exercises, and physical agents can be used to address the associated pain, muscular tightness, weakness, and physical disability.

Interestingly, previous efforts that applied traction (decompression) on the arthritic knee joint demonstrated favorable results even on the thickness of the articular cartilage. However, these methods were mainly invasive surgical procedures that encountered disadvantages like the risk of infection and prolonged bedridden that might affect the general health of the patients

03

Conditions studied

  • Knee Osteoarthritis
04

Who can participate

Ages eligible
45 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Both sexes
  • age between 45 to 60 years.
  • Normal and or overweight categories of 19-30 kg/m2
  • Unilateral (grade 2 and 3) knee OA according to the Kellgren-Lawrence radiological rating scale

Exclusion criteria

Exclusion Criteria:

  • lower limb deformities as genu varum, valgus, flat foot
  • leg length discrepancy
  • previous trauma and or surgery to the knee joint
  • Bone disease
  • Inability to refrain from analgesic/anti-inflammatory medications for 6 weeks
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
75 participants (actual)

Study arms

  • Active comparator
    Standard physical therapy program

    All Patients in the three groups will receive supervised systematic exercise therapy that was performed effectively in previous work. This program consisted of lower limb static, dynamic, and flexibility exer¬cises that targeted the quadriceps, hamstrings, and gluteus muscles; and core strength training for 20 minutes per day. This program will be applied 3 times per week for 6 weeks

    Other: standard physical therapy

  • Experimental
    knee Decompression

    The ACUTRAC AT270 Traction System device will be used for traction. The patient will assume the supine position with the hip of the treated limb in semi-flexion and the ipsilateral knee in 25-30º flexion. 15 minutes of continuous mechanical traction using 20% of the patient's weight will be used. The session will be 15 minutes, once a day, three-times a week for 6 weeks. This group will receive decompression and standard physical therapy.

    Other: standard physical therapy · Other: knee Decompression

  • Experimental
    Decompression plus heating

    this group will receive the standard physical therapy, the mechanical decompression and superficial heating using heat pad on the knee joint for 20 minutes while the patient receives the decompression session

    Other: standard physical therapy · Other: knee Decompression · Other: hot pack

Interventions

  • Otherstandard physical therapy

    All Patients in the three groups will receive supervised systematic exercise therapy that was performed effectively in previous work. This program consisted of lower limb static, dynamic, and flexibility exer¬cises that targeted the quadriceps, hamstrings, and gluteus muscles; and core strength training for 20 minutes per day. This program will be applied 3 times per week for 6 weeks to all the participants

    Also known as: routine physical therapy

  • Otherknee Decompression

    continuous mechanical decompression using 20% of the body weight as a traction force for 15 minutes.

    Also known as: knee traction

  • Otherhot pack

    hot pack over the treated knee joint will be applied for 20 minutes. this application will be performed while the patient is receiving the decompression session

    Also known as: superficial heating, moist heat

06

What researchers measure

Primary outcomes

  1. pain intensity

    Visual Analog Scale (VAS) will be used to assess pain. This scale is proved to be valid and reliable mean of assessing pain. The patient's pain intensity is represented by a point between the extremes of "no pain at all" and "worst pain imaginable." The outcomes range between no pain to sever pain according to the distance in mm measured from the 0 point of the horizontal line.

    Time frame: at base line

  2. pain intensity

    Visual Analog Scale (VAS) will be used to assess pain. This scale is proved to be valid and reliable mean of assessing pain. The patient's pain intensity is represented by a point between the extremes of "no pain at all" and "worst pain imaginable." The outcomes range between no pain to sever pain according to the distance in mm measured from the 0 point of the horizontal line.

    Time frame: after the end of the treatment (after 6 weeks)

  3. active knee range of motion

    this outcome will be assessed using a vlaid and reliable android-mobile application designed to assess joint range of motion (ROM). The mobile phone will be secured to the lateral aspect of the leg so that the normal extension will be represented as zero on the app screen. The patient will be asked to move the tested knee from the maximum extension to the maximum available flexion. The value of the angle will be recorded. The difference between the extension angle and flexion angle will be calculated.

    Time frame: at baseline

  4. active knee range of motion

    this outcome will be assessed using a vlaid and reliable android-mobile application designed to assess joint range of motion (ROM). The mobile phone will be secured to the lateral aspect of the leg so that the normal extension will be represented as zero on the app screen. The patient will be asked to move the tested knee from the maximum extension to the maximum available flexion. The value of the angle will be recorded. The difference between the extension angle and flexion angle will be calculated.

    Time frame: after the end of the treatment (after 6 weeks)

  5. function

    It is consisted of 24 questions, five related to pain, two related to stiffness and 17 to physical function. Its reliability was proved in previous work.the questions in this scale takes from 0 to 4 points and the total will be calculated. higher scores indicate more disability

    Time frame: at baseline

  6. function

    It is consisted of 24 questions, five related to pain, two related to stiffness and 17 to physical function. Its reliability was proved in previous work.the questions in this scale takes from 0 to 4 points and the total will be calculated. higher scores indicate more disability

    Time frame: after the end of the treatment (after 6 weeks)

07

Study locations

1 site
  • Hisham Hussein
    Ha'il, Ha'il Region 3994, Saudi Arabia
08

References and documents

Individual participant data

Plan to share: No — the data will be available with the senior author up on request

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2026 to primary completion in Jul 2026, 6 months.

Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's 6 months is below that.

Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 26, 2026: start Jun 2024 → Jan 2026, primary completion Dec 2024 → Jul 2026 and completion Dec 2024 → Jul 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 20, 2024
First posted
May 24, 2024
StartActual
Jan 15, 2026was Jun 2024
Primary completionActual
Jul 30, 2026was Dec 2024
CompletionActual
Jul 30, 2026was Dec 2024
Last update
Oct 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
1 site added, 1 site removed
Show site
  • Hisham Hussein · Ha'il, Saudi Arabia
Show 1 removed
  • Hisham Hussein · Hail, Saudi Arabia
Oct 26, 2026
Start date
Jun 15, 2024→Jan 15, 2026
Oct 26, 2026
Primary completion
Dec 30, 2024→Jul 30, 2026
Oct 26, 2026
Study completion
Dec 30, 2024→Jul 30, 2026
Oct 26, 2026
Show all 1 update
  1. Oct 26, 2026
    1 site added, 1 site removed
    Show site
    • Hisham Hussein · Ha'il, Saudi Arabia
    Show 1 removed
    • Hisham Hussein · Hail, Saudi Arabia
    Start date Jun 15, 2024→Jan 15, 2026
    Primary completion Dec 30, 2024→Jul 30, 2026
    Study completion Dec 30, 2024→Jul 30, 2026
    + 2 other changes: index terms and verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06428071
Lead sponsor
University of Hail
Responsible party
Hisham Mohamed Hussein (principal investigator, University of Hail) — Principal investigator
First posted
May 24, 2024
Start date
Jan 15, 2026
Primary completion
Jul 30, 2026
Completion
Jul 30, 2026
Last update
Oct 26, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion